An overview of clinical trial data on a new formulation of botulinum neurotoxin type A.
Jewell
Mark L
ML
Oregon Health Science University, Portland, OR, USA. mjewell@teleport.com
Monheit
Gary D
GD
D000368:Aged; D019274:Botulinum Toxins, Type A / Q000627:therapeutic use*; D002626:Chemistry, Pharmaceutical; D002986:Clinical Trials as Topic; D003357:Cosmetic Techniques / Q000639:trends*; D006801:Humans; D009498:Neurotoxins / Q000008:administration & dosage / Q000009:adverse effects*; D012060:Rejuvenation
D009498:Neurotoxins; D019274:Botulinum Toxins, Type A; C542869:abobotulinumtoxinA